← Eichor
Study identifier: NCT05879835 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure

Condition: Pediatric Intestinal Failure  ·  Sponsor: SterileCare Inc.

PhaseNA
Planned participants124
Who can joinAll sexes, 4 Weeks to 18 Years
Healthy volunteersNo

About this study

A multi-site, randomized, 2-arm open-label trial to determine if 4% Tetrasodium (EDTA) catheter lock solution is more effective than heparin lock (standard of care) in preventing central venous catheter occlusions in children with intestinal failure (IF) on total parenteral nutrition (TPN).

This description comes directly from the study's public registry record.

Talk to the study team

Joanne Greco  ·  6472006232  ·  jgreco@sterilecareinc.com

Always discuss trial participation with your own doctor first.

Locations (8)

Boston Children's HospitalBoston, Massachusetts, United StatesRecruiting
University of Nebraska Medical CenterOmaha, Nebraska, United StatesNot Yet Recruiting
Nyph/CumcNew York, New York, United StatesRecruiting
Duke University Medical CenterDurham, North Carolina, United StatesRecruiting
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio, United StatesRecruiting
Nationwide Children's HospitalColumbus, Ohio, United StatesRecruiting
Cook Children's Health Care SystemFort Worth, Texas, United StatesRecruiting
Seattle Children's HospitalSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05879835